Literature DB >> 9647893

Genetic influences on smoking: candidate genes.

M A Rossing1.   

Abstract

Twin studies consistently indicate important genetic influences on multiple aspects of smoking behavior, including both initiation and cessation; however, knowledge regarding the role of specific genes is extremely limited. Habit-forming actions of nicotine appear to be triggered primarily at nicotinic receptors on the cell bodies of dopaminergic neurons in the mesolimbic "reward" system of the brain, a region implicated in addiction to other substances including cocaine, opiates, and alcohol. Important aspects of the dopaminergic pathway include synthesis of dopamine in dopaminergic neurons, release of dopamine by presynaptic neurons, receptor activation of postsynaptic neurons, dopamine re-uptake by presynaptic neurons, and metabolism of released dopamine. Research examining the role of allelic variation in genes involved in these functions is being actively pursued with respect to addictive behavior as well as personality traits and psycho- and neuropathologic conditions and has implications for smoking research. In addition, genetic differences in nicotinic receptors or nicotine metabolism might reasonably be hypothesized to play a role in smoking addiction. A role of dopaminergic or other genes in smoking cessation is of particular potential importance, as research in this area may lead to the identification of subgroups of individuals for whom pharmacologic cessation aids may be most effective.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647893      PMCID: PMC1533105          DOI: 10.1289/ehp.98106231

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  126 in total

1.  Immunotherapy for cocaine addiction.

Authors:  D W Landry
Journal:  Sci Am       Date:  1997-02       Impact factor: 2.142

2.  A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample.

Authors:  I Pérez de Castro; J Santos; P Torres; G Visedo; J Saiz-Ruiz; C Llinares; J Fernández-Piqueras
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

3.  G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease.

Authors:  T Xie; S L Ho; L S Li; O C Ma
Journal:  Mov Disord       Date:  1997-05       Impact factor: 10.338

4.  Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder.

Authors:  B Gutiérrez; J Bertranpetit; R Guillamat; V Vallès; M J Arranz; R Kerwin; L Fañanás
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

Review 5.  Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.

Authors:  J D Elsworth; R H Roth
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

6.  Association of a monoamine oxidase B allele with Parkinson's disease.

Authors:  J H Kurth; M C Kurth; S E Poduslo; J D Schwankhaus
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

7.  Lack of association between alcohol-dependence and D3 dopamine receptor gene in three independent samples.

Authors:  P Gorwood; M P Martres; J Adès; P Sokoloff; E P Noble; T Geijer; K Blum; J Neiman; E Jönsson; J Feingold
Journal:  Am J Med Genet       Date:  1995-12-18

8.  No evidence of association between structural polymorphism at the dopamine D3 receptor locus and alcoholism in the Japanese.

Authors:  S Higuchi; T Muramatsu; S Matsushita; M Murayama
Journal:  Am J Med Genet       Date:  1996-07-26

Review 9.  Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.

Authors:  A Hitri; Y L Hurd; R J Wyatt; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1994-02       Impact factor: 1.592

10.  Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6.

Authors:  A Llerena; G Edman; J Cobaleda; J Benítez; D Schalling; L Bertilsson
Journal:  Acta Psychiatr Scand       Date:  1993-01       Impact factor: 6.392

View more
  7 in total

1.  Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers.

Authors:  Song Guo; Da Fang Chen; Dong Feng Zhou; Hong Qiang Sun; Gui Ying Wu; Colin N Haile; Therese A Kosten; Thomas R Kosten; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2007-01-06       Impact factor: 4.530

2.  The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.

Authors:  Mindi A Styn; Tomoko Nukui; Marjorie Romkes; Kenneth Perkins; Stephanie R Land; Joel L Weissfeld
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

Review 3.  Narrative review of genes, environment, and cigarettes.

Authors:  Elizabeth Do; Hermine Maes
Journal:  Ann Med       Date:  2016-04-28       Impact factor: 4.709

4.  Concordance rates for smoking among African-American twins.

Authors:  Keith E Whitfield; Gary King; Stephanie Moller; Christopher L Edwards; Tracy Nelson; David Vandenbergh
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

Review 5.  Stress-sensitive neurosignalling in depression: an integrated network biology approach to candidate gene selection for genetic association analysis.

Authors:  J Anke M van Eekelen; Justine A Ellis; Craig E Pennell; Jeff Craig; Richard Saffery; Eugen Mattes; Craig A Olsson
Journal:  Ment Illn       Date:  2012-12-18

6.  An exploratory study on the development of an animal model of acute pancreatitis following nicotine exposure.

Authors:  P Chowdhury
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

7.  Environmental smoking and smoking onset in adolescence: the role of dopamine-related genes. Findings from two longitudinal studies.

Authors:  Marieke Hiemstra; Marloes Kleinjan; Onno C P van Schayck; Rutger C M E Engels; Roy Otten
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.